SCHEMBL7973281

SCHEMBL7973281

NC(=O)N(O)[C@H]1CC[C@H](c2ccccc2)CC1

nearest known ligand 0.46

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.46
AKR1C1 Q04828 1/20 0.46
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
ALOX5 P09917 2/20 0.43
KDM4E B2RXH2 2/20 0.43
HSD11B1 P28845 1/20 0.42
SIGMAR1 Q99720 2/20 0.41
SLC18A3 Q16572 3/20 0.40
NPY5R Q15761 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7969789 1.00 AKR1C3 (0.46) AKR1C3AKR1C1NPC1RAB9AALOX5
SCHEMBL7969786 1.00 AKR1C3 (0.46) AKR1C3AKR1C1NPC1RAB9AALOX5
SCHEMBL7972821 0.90 AKR1C3 (0.51) AKR1C3AKR1C1NPC1RAB9AALOX5
SCHEMBL7972824 0.90 AKR1C3 (0.51) AKR1C3AKR1C1NPC1RAB9AALOX5
SCHEMBL7959801 0.90 AKR1C3 (0.51) AKR1C3AKR1C1NPC1RAB9AALOX5
SCHEMBL7973213 0.90 AKR1C3 (0.51) AKR1C3AKR1C1NPC1RAB9AALOX5
SCHEMBL7973212 0.90 AKR1C3 (0.51) AKR1C3AKR1C1NPC1RAB9AALOX5
SCHEMBL7973050 0.84 ALOX5 (0.56) AKR1C3AKR1C1ALOX5KDM4E
SCHEMBL7969402 0.84 ALOX5 (0.56) AKR1C3AKR1C1ALOX5KDM4E
SCHEMBL7969404 0.84 ALOX5 (0.56) AKR1C3AKR1C1ALOX5KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6291520-B1 INHIBIT THE ENZYME LIPOXYGENASE; TREATMENT OR ALLEVIATION OF INFLAMMATORY DISEASES, ALLERGIC CONDITIONS AND CARDIOVASCULAR DISEASES PFIZER 2001-09-18 US disclosed
EP-0559743-B1 NOVEL HYDROXAMIC ACID AND N-HYDROXYUREA DERIVATIVES AND THEIR USE PFIZER (US) 1995-03-08 EP disclosed